Mangoceuticals (MGRX) Debt Ratio (2022 - 2026)
Mangoceuticals (MGRX) posted Debt Ratio of 0.08 for Q4 2022.
Mangoceuticals (MGRX) Debt Ratio (2022 - 2026) Analysis & Trends
Mangoceuticals has reported Debt Ratio for 1 years, with the latest figure at 0.08 in Q4 2022.
- Quarterly Debt Ratio changed N/A year-over-year to 0.08 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.08 (changed N/A YoY) and the FY2022 annual result came in at 0.08, changed N/A from the prior year.
- Debt Ratio held at 0.08 in Q4 2022 per MGRX's latest filing.
- Over five years, Debt Ratio peaked at 0.08 in Q4 2022 and troughed at 0.08 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 0.37 |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 0.29 |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 0.25 |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Dec 31, 2022 | 0.08 |